Upbeat US Data Lifts Western Markets

Published 06/28/2012, 06:34 AM
Updated 05/14/2017, 06:45 AM
Equities

Asian markets traded mostly higher on Wednesday, led by the Hang Seng’s 1% gain to 19177. The Nikkei climbed .8% to 8730, ending a 3-day losing streak, and the ASX 200 advanced .7% to 4043. The Kospi closed flat, while the Shanghai Composite slipped .2%.

Upbeat US home sales data sent European markets sharply higher in afternoon trading. The CAC40 jumped 1.7% to 3063, the FTSE climbed 1.4% to 5524, and the DAX rallied 1.5% to 6229. German chancellor Angela Merkel remains firmly opposed to any shared debt liabilities, limiting the potential outcome of the 2-day European Summit, scheduled to begin on Thursday.

US stocks rose as well, but the gains were less impressive. The Dow tacked on 92 points to 12627, the S&P 500 advanced .9% to 1332, and the Nasdaq gained .7% to 2875.
DJI CHART
Dow Rises 92 Points
The FDA approved Locaserin, an anti-obesity drug produced by Arena Pharmaceuticals, sending the company’s shares soaring 28.7%.

Currencies
European currencies slipped ahead of the European Summit, as the pound sank .5% to 1.5564, and the Swiss franc and euro eased .2% to .9636 and 1.2465 respectively. The Australian dollar and Canadian dollar both edged up .2%, while the yen slipped .2% to 79.71.

Economic Outlook
Pending home sales surged 5.9% last month, blowing past forecasts for a 1.2% gain. Durable goods orders rose by 1.1%, more than expected.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.